No Picture
News

Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today […]

No Picture
News

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

The Company is seeking strategic opportunities to advance the development of this program SAN DIEGO, March 23, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer […]

No Picture
News

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated […]

No Picture
News

Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS

If approved, tofersen will be the first treatment targeting a genetic cause of ALS and the next marketed Ionis-discovered antisense medicine FDA decision expected by April 25, 2023 CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — […]

No Picture
News

DrTalks Presents The Reverse Inflammaging Body and Mind Longevity Medicine Summit to Take Place Virtually on April 25th-May 2nd, 2023

CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — DrTalks.com is pleased to announce the upcoming Reverse Inflammaging Body and Mind Longevity Medicine Summit from April 25th to May 2nd, 2023. The summit will be hosted by […]

No Picture
News

Technosylva Adds Three New Members to Board

LA JOLLA, Calif. & LEON, Spain–(BUSINESS WIRE)–Technosylva Inc., the leading wildfire science and technology company that operationalizes wildfire science, providing proven wildfire risk analysis solutions to enhance daily decision making for fire agencies and electric […]

No Picture
News

Club Kokomo Spirits Partners with Speakeasy Co. to Launch Online Storefront and Direct-to-Consumer Shipping Nationwide

SAN DIEGO, March 22, 2023 /PRNewswire/ — New premium cocktail and spirits company Club Kokomo Spirits and Speakeasy Co. have announced a distribution partnership, making the California-born brand immediately available to consumers across 34 Sates. […]

No Picture
News

Clinicians Identify Buprenorphine “Spiking” In JAMA Psychiatry Study Supported by Millennium Health Researchers

SAN DIEGO–(BUSINESS WIRE)–A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, […]

No Picture
News

Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant from National Heart, Lung, and Blood Institute

Award supports design and preclinical testing of pediatric stent SAN DIEGO, March 22, 2023 /PRNewswire/ — Starlight Cardiovascular, Inc., a medical device company developing pediatric cardiovascular devices, announced that it has been awarded a Small […]

No Picture
News

A NEW STUDY SUGGESTS ENERGY4LIFE’S BIOENERGETIC WEARABLE DEVICE MAY HAVE POSITIVE EFFECTS ON CELLULAR MEMBRANE

The study, led by Professor Hemal Patel, Vice-Chair of Medical Research at University of California at San Diego, observed positive unique and cell-specific effects on cellular membrane structure, mitochondrial function, oxidative stress, and viral infection […]

No Picture
News

Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel

SAN DIEGO & PHILADELPHIA–(BUSINESS WIRE)–Capstan Therapeutics, Inc., a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted lipid nanoparticles, today announced the appointment of Justin Thacker as Chief Financial Officer and Jeffrey […]

No Picture
News

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will present […]